Search the web
Welcome, Guest
[Sign Out, My Account]
Morningstar_Inc.

Monday, September 1 2014 5:44pm ET - U.S. Markets Closed.
Industry Center - Biotechnology
Industry Center > Biotechnology
More On This Industry
Summary
·News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Diversified Utilities
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
·Tobacco Products, Other
Complete Industry List...
Morningstar Inc.
In-depth Company Dossier Reports on over 7,500 publicly traded U.S. companies. Click here for your free report.
  
Industry Market Summary
Biotechnology
Composite Value: 1555.1
Today's Change: -0.49%
S&P 500: +0.33%
chart for
[Biotechnology (^YHOh788)]
Biotechnology News
Study raises concerns over Servier, Amgen heart drug
Sun 10:30 am ET (Reuters)
A major clinical study has raised concerns about a drug from private French company Servier that helps lower the heart rate and which was licensed to U.S. Ivabradine is not currently approved in the United States but it is sold in Europe for treating stable angina, or chest pain due to obstruction of heart arteries, and for heart failure, when the heart fails to pump blood effectively. The increase in the combined risk of cardiovascular death and heart attack in this patient group was small but statistically significant, with 7.6 percent of them suffering an adverse event against 6.5 percent of those on placebo. A commentary in the New England Journal of Medicine, where the results were also published, said more research was needed to understand the finding and in the meantime doctors should "exercise caution" in using the drug in severe angina patients.
Early data suggest Sanofi, Regeneron drug may halve heart risk - (Reuters)
[video] Keep chasing biotech stocks? - (at CNBC)
More News on Biotechnology: Latest News,
Industry Top Performers
Intraday Price Performance% ChangeMarket Cap
NOVACYT [ALNOV.PA] +18.56% $0
Synthetic Biologics, Inc. Commo [SYN] +13.91% $153.1 M
NUVO RESEARCH INC [NRI.TO] +12.92% $0
EPIGENOMICS [ECX.DE] +11.79% $0
BELLUS HEALTH INC. [BLU.TO] +9.93% $108.4 M
More Top Intraday Price Performers...
Market Capitalization% ChangeMarket Cap
SHIRE [SHP.L] -1.20% $2885.5 B
GILEAD SCIENCES [GILD.MX] -1.17% $2107.3 B
SUN PHARMA- DEPO SETT [SUNPHARMA.NS] -1.51% $1775.0 B
AMGEN [AMGN.MX] -0.03% $1368.2 B
Gilead Sciences, Inc. [GILD] +0.05% $162.6 B
More Top Companies by Market Cap...
More Top Performers: by Valuation, by Growth, by Financial Strength
Industry Calendar
Upcoming Events
Date Co Event
09/03/14 PLX Protalix Biotherapeutics Inc Corporate Call to Discuss ELELYSO Pediatric Approval and Provide Updates on Additional Programs
09/09/14 ABC.L Full Year 2013 Abcam PLC Earnings Release
09/10/14 TNG.PA Half Year 2014 Transgene SA Earnings Release
More Upcoming Events...
Recent Events
Date Co Event
08/28/14 IG IGI, Laboratories Inc. Common S coverage initiated by Oppenheimer
08/28/14 ITMN InterMune, Inc. downgraded by UBS
08/27/14 ADHD Alcobra Ltd. coverage initiated by FBR Capital
More Recent Events...
Sponsor Results
Dr0zs Wrinkle Secret - $5
Read this special report (on Dr0zs) on 1 new Wrinkle Cream that Works!
antiagingworld.org/5DollarCream
Leading Biotech Companies
New Products, Marketing Tactics Business Strategies, Joint Ventures
www.vpgmarketresearch.com
Biotechnology Company
Go To Local.com To Find Local Businesses And Services Near You!
Local.com
(What's This?)
  
Locate Industry by Company
Enter Symbol:
Industry Statistics
Market Capitalization:9,744B
Price / Earnings:NM
Price / Book:30.5
Net Profit Margin (mrq):6.7%
Price To Free Cash Flow (mrq):-115.5
Return on Equity:5.1%
Total Debt / Equity:50.2
Dividend Yield:1.8%
View Industry Browser
Community Spotlight
Most Active Boards
Board Popularity
CTRX
PGLAF
NRPH
Unusually Active Boards
Board Variance
CTRX
NRPH
PDLI

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Biotechnology Headlines
More Finance RSS Feeds


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?